A comprehensive analysis of the “Europe Tumor Ablation Market” for the Germany, United Kingdom, France, Spain, Italy, Russia, Turkey, Belgium, Nether lands, Switzerland, Rest of Europe, which includes market sizing, market share by competitors, drivers, restraints and market forecasts to 2024.
Pune, India -- (SBWIRE) -- 02/19/2018 -- Europe Tumor Ablation Market is expected to reach USD 1,042.3 million by 2024 from USD 484.2 million in 2016, at a CAGR of 10.2% in the forecast period 2017 to 2024.
Europe Tumor Ablation Market By Type (Tumor Ablation Systems {Radio Frequency Ablation System, Microwave Ablation System, Cryoablation, High Intensity Focused Ultrasound , Laser Ablation System}, Image Guidance Products, Accessories), By Cancer Type (Liver Cancer, Brain Cancer, Lung Cancer, Bone Cancer, Kidney Cancer, Pancreatic Cancer, Breast Cancer, Others), By Mode of Treatment (Surgical, Laparoscopic, Percutaneous), By End User (Hospitals, Oncology Clinics, Others), Country (Germany, United Kingdom, France, Spain, Italy, Russia, Turkey, Belgium, Nether lands, Switzerland, Rest of Europe)– Industry Trends and Forecast to 2024
Get Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=europe-tumor-ablation-market
The major factors driving the growth of this market are the increasing aging population; unbalanced diet is leading to large number of cases of cancer, government initiatives to promote the treatment of cancer by ablation therapy. On the other hand, side effects associated with ablation treatment may hinder the growth of the market. The tumor ablation market in the Europe region is leading in Germany.
If you want to purchase this report kindly send the email @ Sales@databridgemarketresearch.com
Segmentation of Europe Tumor Ablation Market:
The Europe tumor ablation market is segmented on the basis of type, cancer type, mode of treatment and end-user. Based on type, the Europe tumor ablation market is segmented into tumor ablation systems, image guidance product and accessories. In 2017, tumor ablation systems market segment is expected to account for the largest share of 69.3% of the Europe tumor ablation market.
On the basis of cancer type, the Europe tumor ablation market is segmented into liver cancer, brain cancer, lung cancer, bone cancer, kidney cancer, pancreatic cancer, breast cancer, and others. In 2017, the breast cancer segment is expected to dominate the market with 35.5% market share.
On the basis of mode of treatment, the Europe tumor ablation market is segmented into non-invasive method and invasive method.
By application, the Europe tumor ablation market is segmented into antepartum surgical, laparoscopic, and percutaneous. Laparoscopic is the highest growing segment with the highest CAGR of 11.1% in the forecast period 2017 to 2024.
On the basis of end users, the Europe tumor ablation market is classified hospitals, oncology clinics, and others. Among these, in 2017 hospitals segment dominated the market and the trend is expected to remain the same till 2024.
Have Any Query? Ask Ours Expert @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=europe-tumor-ablation-market
Key Points of Europe Tumor Ablation Market:
Medtronic is going to dominate the Europe tumor ablation market following with Boston Scientific Corporation and Abbott along with others such as NeuWave Medical, Inc., Koninklijke Philips N.V., INTIO Inc., Mermaid Medical A/S, SonaCare Medical, LLC, DFINE, Inc., Misonix, BVM Medical Limited, AngioDynamics, COMSOL Inc.
- Tumor ablation systems segment is expected to dominate the Europe tumor ablation market.
- The tumor ablation market in the Europe region is leading in France, U.K., Germany and Italy. Germany accounts for the highest market share in this region.
Key Drivers of Europe Tumor Ablation Market:
Europe is the growing market for tumor ablation. The growth in this market is due to increasing aging population, unbalanced diet is leading to large number of cases of cancer, government initiatives to promote the treatment of cancer by ablation therapy. Various product launches in Europe market will boost the tumor ablation market.
- Investment of money in cancer research for various new and emerging technologies such as intensity modulated radiotherapy, photon beam therapy and in clinical trials will make the demand for tumor ablation.
Read more about the Europe Tumor Ablation Market Visit @ http://databridgemarketresearch.com/reports/europe-tumor-ablation-market/
Related Report
Global Healthcare IT Market – Trends and Forecast to 2024
Global Healthcare IT Market, By Product (EHR, RIS, PACS, VNA, CPOE, MHealth, Telehealth, Healthcare Analytics, Supply Chain Management, Revenue Cycle Management, CRM, Claims Management, Fraud Management), By End User (Providers (Hospitals, ASC's, Home Healthcare, Diagnostic Centers, Pharmacies), Payers (Private, Public)), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Trends and Forecast to 2024
Report Access: http://databridgemarketresearch.com/reports/global-healthcare-it-market/
About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research